Top Markets
Coin of the day
China Biotech Services Holdings Limited China Biotech Services Holdings Limited

China Biotech Services Holdings Limited

8037
주식 순위 #23175
Established in 1996 and based in Causeway Bay, Hong Kong, China Biotech... Established in 1996 and based in Causeway Bay, Hong Kong, China Biotech Services Holdings Limited functions as an investment holding company. Its core business involves providing medical laboratory testing and health check services throughout mainland China and Hong Kong. The company organizes its varied operations into five main divisions: Immunotherapy, Pharmaceutical Products, Medical and Health Related Services, Securities, and Insurance Brokerage, in addition to other undertakings. Its comprehensive activities include the research, development, manufacturing, and sale of both health-related and pharmaceutical products. The company also offers specialized medical services, such as tumor immune cell therapy, immune cell storage, and health management programs, alongside coordinating healthcare providers. Furthermore, it participates in financial services like securities trading, money lending, and providing insurance brokerage. Its commercial ventures also extend to marketing and distributing a range of wellness products, including health supplements, slimming aids, traditional Chinese medicines, and beauty products, as well as trading pharmaceutical intermediates. Property investment and logistics services round out its operational scope. The company transitioned to its current name in November 2017, having previously been known as Rui Kang Pharmaceutical Group Investments Limited.
주가
$0.07931426
마지막 동기화: 2026-08-21
시가총액
$77.39M
변동 (1일)
0.81%
변동 (1년)
-49.20%
국가
HK
거래 China Biotech Services Holdings Limited (8037)

카테고리

China Biotech Services Holdings Limited (8037)의 EPS
2026 기준 EPS TTM: 0
China Biotech Services Holdings Limited의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 0입니다. 2026년 말에는 회사의 EPS가 0였으며, 이는 2026년의 EPS 0와 동일입니다.
China Biotech Services Holdings Limited의 EPS 기록 (2026 ~ 2026)
매년 말의 EPS
연도 EPS 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 EPS